• Home
  • News
  • Coins2Day 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Health

Seizures, croup, and mechanical ventilation: New study shows how severe Omicron can get in unvaccinated children

By
Erin Prater
Erin Prater
Down Arrow Button Icon
By
Erin Prater
Erin Prater
Down Arrow Button Icon
April 2, 2022, 9:23 AM ET

Omicron has gained a reputation for being relatively mild—a nice trade-off, given that it’s said to be more than four times more transmissible than Delta.

But a study published to British medical journal The Lancet last week found that Omicron BA.2, or “stealth Omicron”—currently the world’s dominant variant—is not as mild as one might think, at least not in unvaccinated children.

The study, which has yet to be peer-reviewed, examined the medical records of all Hong Kong children ages 0-11 who were hospitalized with COVID during the Omicron BA.2 dominant wave, Feb. 5 to Feb. 28, and compared them to the records of children who had been hospitalized during times of other COVID variant dominance, as well as influenza and parainfluenza dominance before the pandemic.

It found that, among children hospitalized with COVID during the Omicron BA.2 wave:

  • Deaths were higher than they were during other COVID variants, influenza, and parainfluenza.
  • Pediatric ICU admissions were higher than they were during other COVID variants and influenza.
  • Cases of neurological complications, including seizures, were elevated when compared to influenza and parainfluenza.
  • Rates of croup were higher than they were during other COVID variants and influenza.
  • The need for mechanical ventilation and oxygen was higher than it was during other COVID variants and the flu.

The authors’ conclusion: Omicron BA.2 “is not mild, as evident by fatality and severe complications of the uninfected and unvaccinated children.”

Rates of COVID in Hong Kong were incredibly low for first two years of the pandemic, thanks to the government’s “zero COVID” policy with strict interventions. As ABC News reported last month, the region was a “poster child for COVID control, after going long stretches of last year without a single reported infection.” Now stealth Omicron is sweeping the country, and its death rate is the highest in the developed world, according to ABC.

Vaccines weren’t approved for children in Hong Kong until mid-January. The vast majority of children in the study hadn’t been previously infected or vaccinated, according to the study, giving scientists a rare glimpse at the effects of “stealth Omicron” on a population with little to no previous exposure to the virus.

Hardest hit among Hong Kong’s population of hospitalized children were those 5 years and older, who comprised 80% of the 1,147 hospitalized in February. Of the four deaths that occurred, three of the children were under the age of 5. Researchers speculated that the country’s youngest age group may have been hit the hardest due to lack of exposure to other seasonal coronaviruses over the past two years, in addition to a lack of vaccination.

In a commentary titled “Omicron severity: milder but not mild,” published in The Lancet in January, two World Health Organization-affiliated authors pointed out that a “generally young South African population” saw more than 20% of patients hospitalized with Omicron experience a “severe clinical outcome.” A population with lower levels of immunity from vaccines or prior infections could see a higher rate, they said.

“This report of typically milder disease following infection with the omicron versus delta variant in South Africa is encouraging, but we should not assume that omicron variant epidemics will have such a low health effect elsewhere,” they wrote.

Never miss a story: Follow your favorite topics and authors to get a personalized email with the journalism that matters most to you.

About the Author
By Erin Prater
See full bioRight Arrow Button Icon
Rankings
  • 100 Best Companies
  • Coins2Day 500
  • Global 500
  • Coins2Day 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Coins2Day Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Coins2Day Brand Studio
  • Coins2Day Analytics
  • Coins2Day Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Coins2Day
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Coins2Day Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Coins2Day Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.